by Dom Partridge | Oct 21, 2025 | Industry insights
Written by Gwennie Ogilby (Associate Systematic Review Analyst) and Tom Metcalf (Senior Systematic Review Analyst) Systematic literature reviews (SLRs) are considered one of the strongest forms of evidence to guide healthcare policy and inform future research....
by Dom Partridge | Oct 16, 2025 | Industry insights
Written by Dan Spacie, CEO of SCIRIS Executive Summary Market access services are undergoing a dual transformation. On one hand, technological advances and procurement pressures are driving commoditisation—standardising deliverables and compressing margins. On...
by Dom Partridge | Sep 5, 2025 | Industry insights
Written by Luke Parkes Introduction Newborn screening (NBS) is an impactful public health initiative that enables the diagnosis of severe conditions in asymptomatic infants at birth. Typically, NBS programmes include testing for a select number of metabolic and...
by Dom Partridge | May 30, 2025 | Industry insights
Written by Brian O’Toole The National Institute for Health and Care Excellence (NICE) Highly Specialised Technologies (HST) programme is designed to evaluate innovative treatments for rare and complex conditions. On 19th March 2025, NICE announced several...
by Dom Partridge | May 6, 2025 | Industry insights
Written by Susan O’Connell and Sara Bartlome Introduction Systematic literature reviews (SLRs) seek to answer a specific research question by translating the question into search terms and developing a literature search strategy to effectively identify relevant...
by Dom Partridge | Feb 28, 2025 | Industry insights
Written by Aurore Sommer, Medical Writer A disease is considered to be rare when it affects fewer than 1 in 2,000 individuals. To this day, more than 6,000 rare diseases have been identified, affecting around 300 million people globally (1). Rare diseases are...
